These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9014009

  • 1. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S, Katsumoto T, Taniguchi K, Ismail SI, Shimmen T, Sasao F, Gao M, Owatari S, Wakamiya N, Tsuchie H, Ueda S, Shiraki K, Kurimura T.
    Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D, Notkins AL, Zhou P.
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Mar; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 4. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM.
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [Abstract] [Full Text] [Related]

  • 5. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S, Marini E, Bozzo L, Trainini L, Saadoune L, Avolio M, Pontillo A, Bonfanti C, Sarmientos P, Caruso A.
    Biopolymers; 2004 Oct; 76(4):334-43. PubMed ID: 15386266
    [Abstract] [Full Text] [Related]

  • 6. [Anti-HIV-1 p17 antibody as anti-HIV agent].
    Tsuchie H, Tochikura A, Kageyama S, Kurimura T.
    Nihon Rinsho; 1993 Sep; 51 Suppl():213-8. PubMed ID: 8271386
    [No Abstract] [Full Text] [Related]

  • 7. A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV.
    Choudhury AM, Yamada O, Wakamiya N, Kurimura T.
    Microbiol Immunol; 1992 Sep; 36(8):833-40. PubMed ID: 1474934
    [Abstract] [Full Text] [Related]

  • 8. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D, Goldstein SL, Notkins AL, Zhou P.
    J Immunol; 1998 Sep 01; 161(5):2642-7. PubMed ID: 9725267
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A, Tanaka-Taya K, Ueda S.
    Hybridoma; 1999 Apr 01; 18(2):149-57. PubMed ID: 10380014
    [Abstract] [Full Text] [Related]

  • 10. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Apr 01; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 11. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y.
    Microbiol Immunol; 1995 Apr 01; 39(10):775-85. PubMed ID: 8577268
    [Abstract] [Full Text] [Related]

  • 12. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A, Liu X, Fujio H, Sakato N, Ueda S.
    Hybridoma; 1998 Feb 01; 17(1):73-5. PubMed ID: 9523241
    [Abstract] [Full Text] [Related]

  • 13. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA, Morfeldt-Månsson L, Rosen J, Jondal M, Wahren B.
    Clin Exp Immunol; 1989 May 01; 76(2):216-21. PubMed ID: 2503275
    [Abstract] [Full Text] [Related]

  • 14. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
    Shang F, Huang H, Revesz K, Chen HC, Herz R, Pinter A.
    J Virol; 1991 Sep 01; 65(9):4798-804. PubMed ID: 1714518
    [Abstract] [Full Text] [Related]

  • 15. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 16. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
    Ota A, Bautista AN, Yadav ML, Ueda S.
    Hybridoma; 1999 Apr 01; 18(2):139-47. PubMed ID: 10380013
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A.
    Pharmacol Ther; 2010 Dec 01; 128(3):433-44. PubMed ID: 20816696
    [Abstract] [Full Text] [Related]

  • 18. Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
    de Goede AL, Boers PH, Dekker LJ, Osterhaus AD, Gruters RA, Rimmelzwaan GF.
    Vaccine; 2009 Sep 25; 27(42):5735-9. PubMed ID: 19647812
    [Abstract] [Full Text] [Related]

  • 19. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
    Davis D, Donners H, Willems B, Vermoesen T, Heyndrickx L, Colebunders R, van der Groen G.
    J Med Virol; 2003 Nov 25; 71(3):332-42. PubMed ID: 12966537
    [Abstract] [Full Text] [Related]

  • 20. HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha.
    De Francesco MA, Poiesi C, Ricotta D, Manca N.
    Virus Res; 2006 Jun 25; 118(1-2):170-7. PubMed ID: 16427155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.